Chester County News and Community Website
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) has received U.S. Food and Drug Administration authorization for rolling review of its New Drug Application for QTORIN rapamycin, a step that could …
Palvella Secures FDA Rolling Review for Rare Disease Drug Read More
WEST CHESTER, PA — Chester County health inspectors cited multiple food establishments for food safety and equipment violations during inspections conducted June 23, including temperature-control issues that resulted in food …
One Restaurant Received More Than a Dozen Health Violations Read More
WEST CHESTER, PA — A West Chester cafe operating inside a car dealership received one of the most extensive lists of food safety violations identified by the Chester County Health …
West Chester Cafe Cited for Rodents, Food Safety Violations Read More
PHOENIXVILLE, PA — PleoPharma has dosed the first patient in a Phase 3 clinical trial of an investigational treatment for cannabis withdrawal symptoms, advancing a drug candidate that could become …
PleoPharma Begins Phase 3 Trial for Cannabis Withdrawal Drug Read More
A survey of wound care clinicians and practices found that changes to Medicare reimbursement for advanced wound treatment products are contributing to treatment delays, authorization hurdles, and reduced care capacity, …
Survey Links CMS Payment Rule to Wound Care Access Strains Read More
WASHINGTON, D.C. — The Food and Drug Administration is seeking revisions to prescribing information for testosterone replacement therapies after concluding that newer clinical evidence no longer supports certain longstanding restrictions …
FDA Seeks Testosterone Label Changes After Evidence Review Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved the first generic version of Xofluza (baloxavir marboxil), expanding access to a single-dose influenza treatment and prevention option ahead …
FDA Clears First Generic Xofluza Ahead of Flu Season Read More
WASHINGTON, D.C. — The Department of Health and Human Services is making more than $700 million available for addiction, mental health, crisis response, and homelessness-related programs, including a new $96 …
HHS Unveils $708 Million Behavioral Health Funding Push Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has expanded the approved use of Tzield (teplizumab) to children ages 8 to 17 who have been recently diagnosed with Stage …
FDA Expands Tzield Use for Children With Type 1 Diabetes Read More
PLYMOUTH MEETING, PA — Patients with advanced cancer were significantly more likely to discuss and document their care preferences when both they and their physicians received targeted reminders, according to …
Cancer Care Study Finds Targeted Prompts Increase End-of-Life Discussions Read More